Atlas Trials

Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)

Clinical trial NCT02321878 · COMPLETED

Trial details

NCT number
NCT02321878
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2014-12-15
Primary completion
2017-06-16
Enrollment
1092

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.